🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Flávio Steinwurz

Hospital Israelita Albert Einstein

ORCID: 0000-0003-1002-9766

Also affiliated with Pan American Health Organization (Brasil)

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
8.8Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Effect of IBD medications on COVID-19 outcomes: results from an international registry

Gut(2020)10.1136/gutjnl-2020-322539
Top 2%
7.9DataRank
Top 2%282 citations

Erica J. Brenner, Richard B. Gearry, Gilaad G. Kaplan, Michele Kissous-Hunt, James D. Lewis +9 more

Papers

Driven by 7 papers — median percentile 88. Top paper: “Effect of IBD medications on COVID-19 outcomes: results from an international registry”.

Effect of IBD medications on COVID-19 outcomes: results from an international registry

Gut(2020)10.1136/gutjnl-2020-322539
Top 2%
7.9DataRank
Top 2%282 citations

Erica J. Brenner, Richard B. Gearry, Gilaad G. Kaplan, Michele Kissous-Hunt, James D. Lewis +9 more

Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry

Gastroenterology(2020)10.1053/j.gastro.2020.05.032
N/A
0.981DataRank · unranked
689 citations

Ryan C. Ungaro, Richard B. Gearry, Gilaad G. Kaplan, Michele Kissous-Hunt, James D. Lewis +10 more

Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry

Journal of Crohn s and Colitis(2020)10.1093/ecco-jcc/jjaa243
Top 22%
0.900DataRank
Top 22%11 citations

Erica J. Brenner, Xian Zhang, Jean‐Frédéric Colombel, Michael D. Kappelman, Ryan C. Ungaro +11 more

Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus

˜The œLancet. Gastroenterology & hepatology(2022)10.1016/s2468-1253(22)00021-8
N/A
0DataRank · unranked
152 citations

Gilaad G. Kaplan, Çharles N. Bernstein, Kristin E. Burke, Paul Lochhead, Alexa N. Sasson +95 more

Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies

Gastroenterology(2021)10.1053/j.gastro.2021.04.025
N/A
0DataRank · unranked
141 citations

Rebekah E. Dixon, Vicky Martinez Pazos, Sacha Gnjatic, Jean‐Frédéric Colombel, Ken Cadwell +37 more

Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry

Gastroenterology(2021)10.1053/j.gastro.2021.09.011
N/A
0DataRank · unranked
72 citations

Erica J. Brenner, Manasi Agrawal, Xian Zhang, Michael D. Kappelman, Jean‐Frédéric Colombel +9 more

COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States

Clinical Gastroenterology and Hepatology(2021)10.1016/j.cgh.2021.05.060
N/A
0DataRank · unranked
4 citations

Erica J. Brenner, Joyce Wing Yan Mak, Xian Zhang, Gilaad G. Kaplan, Siew C. Ng +9 more